Close
Digital Health & Ai Innovation summit 2026

GE HealthCare to Strengthen AI-Enabled Fetal Ultrasound

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Pulmonary Embolism Research Fund to Target...

AngioDynamics has launched an investigator-led pulmonary embolism research fund...

Johnson & Johnson MedTech Omnypulse Results...

Johnson & Johnson MedTech today reported Johnson & Johnson...

Medicaid Work Requirements Gain $600m Tech...

Medicaid work requirements are set to receive major implementation...

GE HealthCare today announced a collaboration with Diagnoly to advance AI-enabled fetal ultrasound by integrating Diagnoly’s Fetoly solution into GE HealthCare’s Voluson women’s health ultrasound systems. The collaboration focuses on increasing reproducibility, efficiency and diagnostic confidence for prenatal screening exams.

An ultrasound examination is one of the most important tools physicians have to monitor fetal development and detect congenital abnormalities. However, fetal motion, maternal habitus, and user-dependency can adversely impact exam quality. By embedding AI-enabled fetal ultrasound tools into clinical workflows, the collaboration seeks to streamline examinations, reduce clinician workload, and support more standardized assessments.

“AI is redefining what’s possible in healthcare, and GE HealthCare is at the forefront of this movement, as an industry leader bringing AI-powered innovations to clinicians,” said Gerald Seifriedsberger, General Manager, Women’s Health Ultrasound, GE HealthCare. “This collaboration with Diagnoly further expands our ability to integrate advanced AI-based screening support into Voluson ultrasound, helping elevate care for women and their babies.”

Fetoly is a real-time AI solution aligned with International Society of Ultrasound in Obstetrics and Gynecology guidelines. It is designed to support fetal heart and brain analysis while continuously verifying exam completeness and quality criteria during scans, strengthening the Voluson portfolio for clinical use.

“Obstetric ultrasound remains one of the most powerful, but also complex imaging techniques. As a result, up to 50% of fetal abnormalities remain undetected during pregnancy,” said Ivan Voznyuk, Co-Founder and CEO of Diagnoly. “The integration of Fetoly into trusted Voluson ultrasound systems reflects our shared commitment to supporting clinicians in real-time with tools that can help improve maternal and fetal outcomes.”

Fetoly is U.S. Food and Drug Administration 510(k) cleared and CE marked. The AI application is available as a free trial through the Voluson Solution Store and major mobile app platforms.

Latest stories

Related stories

Pulmonary Embolism Research Fund to Target PE Care Gaps

AngioDynamics has launched an investigator-led pulmonary embolism research fund...

Johnson & Johnson MedTech Omnypulse Results Show Promise

Johnson & Johnson MedTech today reported Johnson & Johnson...

Medicaid Work Requirements Gain $600m Tech Industry Support

Medicaid work requirements are set to receive major implementation...

GE Healthcare FDA Clearance For Allia Moveo Imaging System

GE HealthCare FDA clearance marks a key regulatory milestone...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »